Latest News
Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis
...
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
12 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it is donating more than 2,000 vials of remdesivir to the Republic of Uganda to support response efforts to the Ebola Bundibugyo virus disease (BVD) o...
Rocket Pharmaceuticals closes USD180m Rare Pediatric Disease voucher sale
12 June 2026 - Commercial-stage biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced on Friday that it has completed the sale of its Rare Pediatric Disease Priority Review Voucher, generating gross proceeds of USD180m.The voucher ...
ABL Diagnostics secures clinical research contract worth up to EUR2.7m through 2031
12 June 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Friday that it has signed a multi-year contract with a European pharmaceutical company focused on neurodegenerative diseases for services provid...
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
12 June 2026 - Airiver Medical, a clinical stage company developing technologies to help patients with certain respiratory tract conditions, announced on Thursday the successful treatment of the first patient with chronic rhinosinusitis (CRS) in its ...